Antibiotics that affect translation can antagonize phage infectivity by interfering with the deployment of counter-defenses
Proceedings of the National Academy of Sciences · 24.01.2023 · 120 (4)
DOI: 10.1073/pnas.2216084120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 20.01.2023. Verfasst von Benoit J Pons und 3 weiteren Autor:innen. Beteiligte Einrichtung: Environment and Sustainability Institute, Biosciences, University of Exeter, Penryn TR10 9FE, UK. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Bacteriophages. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EC | ERC | HORIZON EUROPE European Research Council (ERC), UKRI | Biotechnology and Biological Sciences Research Council (BBSRC), UKRI | Engineering and Physical Sciences Research Council (EPSRC).
Abstract (Originalsprache)
It is becoming increasingly clear that antibiotics can both positively and negatively impact the infectivity of bacteriophages (phage), but the underlying mechanisms often remain unclear. Here we demonstrate that antibiotics that target the protein translation machinery can fundamentally alter the outcome of bacteria–phage interactions by interfering with the production of phage-encoded counter-defense proteins. Specifically, using Pseudomonas aeruginosa PA14 and phage DMS3vir as a model, we show that bacteria with Clustered Regularly Interspaced Short Palindromic Repeat, CRISPR associated (CRISPR-Cas) immune systems have elevated levels of immunity against phage that encode anti-CRISPR (acr) genes when translation inhibitors are present in the environment. CRISPR-Cas are highly prevalent defense systems that enable bacteria to detect and destroy phage genomes in a sequence-specific manner. In response, many phages encode acr genes that are expressed immediately following the infection to inhibit key steps of the CRISPR-Cas immune response. Our data show that while phage-carrying acr genes can amplify efficiently on bacteria with CRISPR-Cas immune systems in the absence of antibiotics, the presence of antibiotics that act on protein translation prevents phage amplification, while protecting bacteria from lysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Environment and Sustainability Institute, Biosciences, University of Exeter, Penryn TR10 9FE, UK.
ORCID-Profile: Benoit J Pons, Edze R Westra
Förderung
- EC | ERC | HORIZON EUROPE European Research Council (ERC)
- UKRI | Biotechnology and Biological Sciences Research Council (BBSRC)
- UKRI | Engineering and Physical Sciences Research Council (EPSRC)
- European Research Council
Zitieren
APA
Pons, B. J., Dimitriu, T., Westra, E. R., & van Houte, S. (2023). Antibiotics that affect translation can antagonize phage infectivity by interfering with the deployment of counter-defenses. Proceedings of the National Academy of Sciences, 120(4). https://doi.org/10.1073/pnas.2216084120
Vancouver
Pons BJ, Dimitriu T, Westra ER, van Houte S. Antibiotics that affect translation can antagonize phage infectivity by interfering with the deployment of counter-defenses. Proceedings of the National Academy of Sciences. 2023;120(4). doi:10.1073/pnas.2216084120
BibTeX
@article{Pons2023,
author = {Pons, Benoit J and Dimitriu, Tatiana and Westra, Edze R and van Houte, Stineke},
title = {Antibiotics that affect translation can antagonize phage infectivity by interfering with the deployment of counter-defenses},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
volume = {120},
number = {4},
doi = {10.1073/pnas.2216084120}
}
EUVIMED